Article Text

Download PDFPDF
Variation of phenotype in patients with glucocorticoid remediable aldosteronism.
  1. L J Gates,
  2. A A MacConnachie,
  3. R P Lifton,
  4. N E Haites,
  5. N Benjamin
  1. Department of Medicine and Therapeutics, University of Aberdeen, UK.


    Glucocorticoid remediable aldosteronism (GRA), an autosomal dominant cause of primary aldosteronism, has been described as resulting in severe hypertension with premature death from stroke. We describe two new large pedigrees which include subjects who have the abnormal chimaeric gene strongly linked to GRA. The majority of affected members, who have only mild hypertension and normal biochemistry, are clinically indistinguishable from patients with essential hypertension. It is therefore likely that this condition is underdiagnosed.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.